Psychosocial determinants of adherence to oral antidiabetic medication among people with type 2 diabetes
- 19 December 2019
- journal article
- research article
- Published by Wiley in Journal of Clinical Nursing
- Vol. 29 (5-6) , 909-921
Abstract
Aims and objectives: The aim of this study was to identify the psychosocial determinants of adherence to oral antidiabetic medication, according to the Theory of Planned Behaviour (TPB).Background: Appropriate adherence to oral antidiabetic medication contributes to long‐term glycaemic control. However, glycaemic control is often poor in people with type 2 diabetes, mainly due to the poor adherence to oral antidiabetic agents.Design: Prospective study with 2 waves of data collection, based on STROBE checklist was conducted. One hundred and fifty‐seven adults with type 2 diabetes, in chronic use of oral antidiabetic agents, composed the sample. At baseline, self‐reported measures of medication adherence (proportion and global evaluation of adherence) and of metabolic control (glycated haemoglobin) of diabetes were obtained.Methods: The TPB main constructs (attitude, subjective norm and perceived control) and related beliefs were measured. Adherence and metabolic control measurements were obtained in a two‐month follow‐up (n = 157).Results: Attitude and subjective norm, together, explained 30% of the variability in intention; their underlying belief‐based measures (behavioural and normative beliefs) explained 28% of the variability in intention. In addition, intention predicted behaviour at follow‐up. However, when added to the prediction model, past behaviour was the only explanatory factor of adherence behaviour.Conclusion: Adherence behaviour to oral antidiabetic medication was predicted by intention, which, in turn, was determined by attitude and subjective norm. In order to promote adherence to oral antidiabetic agents, health professionals should include motivational strategies as well as strategies targeted to attitude and subjective norm when designing interventions.Relevance to clinical practice: The nonadherence to antidiabetic medication contributes to lack of control of diabetes and ensuing complications. The comprehension of the factors explaining the variability in medication adherence can inform the design of theory‐based interventions aimed at promoting this behaviour.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2010/10006‐8, 2012/05224‐1)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (309827/2012‐4)
- Fundo de Apoio ao Ensino, à Pesquisa e Extensão, Universidade Estadual de Campinas (519.294 n. 337/13)
This publication has 29 references indexed in Scilit:
- Medication Adherence in Patients with Diabetes and Dyslipidemia: Associated Factors and Strategies for ImprovementCurrent Cardiology Reports, 2013
- U.S. emergency departments visits resulting from poor medication adherence: 2005–07Journal of the American Pharmacists Association, 2013
- Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 PatientsThe American Journal of Medicine, 2012
- Factors affecting older persons' adherence to prescription drugs in IsraelNursing & Health Sciences, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Predicting adherence to immunosuppressant therapy: a prospective analysis of the theory of planned behaviourNephrology Dialysis Transplantation, 2007
- Factors Associated with Adherence to Anti-Hypertensive Treatment in PakistanPLOS ONE, 2007
- Determinants of medication adherence in hypertensive patients: an application of self-efficacy and the Theory of Planned BehaviourInternational Journal of Pharmacy Practice, 2006
- Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetesDiabetic Medicine, 2006
- Escala simplificada para detectar problemas de adherencia (ESPA) al tratamiento antirretroviralFarmacia Hospitalaria, 2006